|
|
Exchange: |
New York Stock Exchange |
Security
Type: |
Common |
Shares
Out: |
134,770,000 |
Market
Cap: |
18.67(B) |
Last
Volume: |
667,954 |
Avg
Vol: |
1,170,540 |
52
Week Range: |
$120.62 - $144.92 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Health Services |
Level
III Sector: |
Medical Laboratories & Research |
|
Member Indexes:
|
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
|
S&P 500 |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 724 |
Guru Rank Value : 1.3 |
Guru Occurances : 1 |
|
|
|
|
|
|
|
Company Profile Quest Diagnostics provides diagnostic information services. Co. is made up of two businesses: Diagnostic Information Services, which develops and delivers diagnostic information services, providing insights that allow and enable a range of customers, including patients, clinicians, hospitals, independent delivery networks (including hospital health systems), health plans, employers, accountable care organizations and direct contract entities; and Diagnostic Solutions, which includes Co.'s risk assessment services business, which provides solutions for insurers, and Co.'s healthcare information technology businesses, which provides solutions for healthcare providers.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
1,760 |
18,097 |
18,097 |
100,860 |
Total Sell Value |
$246,400 |
$2,309,019 |
$2,309,019 |
$14,306,288 |
Total People Sold |
1 |
4 |
4 |
6 |
Total Sell Transactions |
1 |
7 |
7 |
21 |
End Date |
2024-03-14 |
2023-12-12 |
2023-06-13 |
2022-06-13 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Davis J. E. |
CEO and President |
|
2023-03-06 |
4 |
A |
$147.86 |
$2,248,063 |
D/D |
15,204 |
110,670 |
|
- |
|
Kuppusamy Karthik |
SVP, Clinical Solutions |
|
2023-03-06 |
4 |
D |
$147.86 |
$86,202 |
D/D |
(583) |
11,241 |
|
- |
|
Kuppusamy Karthik |
SVP, Clinical Solutions |
|
2023-03-06 |
4 |
A |
$147.86 |
$293,502 |
D/D |
1,985 |
11,824 |
|
- |
|
Doherty Catherine T. |
SVP, Regional Businesses |
|
2023-03-06 |
4 |
D |
$147.86 |
$681,635 |
D/D |
(4,610) |
73,117 |
|
- |
|
Doherty Catherine T. |
SVP, Regional Businesses |
|
2023-03-06 |
4 |
A |
$147.86 |
$1,466,328 |
D/D |
9,917 |
77,727 |
|
- |
|
Rusckowski Stephen H |
Director |
|
2023-03-06 |
4 |
D |
$147.86 |
$5,707,987 |
D/D |
(38,604) |
389,597 |
|
- |
|
Rusckowski Stephen H |
Director |
|
2023-03-06 |
4 |
A |
$147.86 |
$12,217,820 |
D/D |
82,631 |
428,201 |
|
- |
|
Deppe Michael J |
SVP, Corp. Controller & CAO |
|
2023-03-06 |
4 |
D |
$147.86 |
$100,841 |
D/D |
(682) |
33,497 |
|
- |
|
Deppe Michael J |
SVP, Corp. Controller & CAO |
|
2023-03-06 |
4 |
A |
$147.86 |
$283,595 |
D/D |
1,918 |
34,178 |
|
- |
|
Plewman Patrick |
SVP for Diagnostic Services |
|
2023-03-06 |
4 |
D |
$147.86 |
$118,140 |
D/D |
(799) |
12,357 |
|
- |
|
Plewman Patrick |
SVP for Diagnostic Services |
|
2023-03-06 |
4 |
A |
$147.86 |
$381,331 |
D/D |
2,579 |
13,145 |
|
- |
|
Prevoznik Michael E |
SVP & General Counsel |
|
2023-03-06 |
4 |
D |
$147.86 |
$567,930 |
D/D |
(3,841) |
43,281 |
|
- |
|
Prevoznik Michael E |
SVP & General Counsel |
|
2023-03-06 |
4 |
A |
$147.86 |
$1,270,857 |
D/D |
8,595 |
47,122 |
|
- |
|
Doherty Catherine T. |
SVP, Regional Businesses |
|
2023-03-03 |
4 |
AS |
$140.63 |
$100,832 |
D/D |
(717) |
67,810 |
|
-0% |
|
Prevoznik Michael E |
SVP & General Counsel |
|
2023-03-02 |
4 |
AS |
$138.54 |
$82,154 |
D/D |
(593) |
38,527 |
|
1% |
|
Kuppusamy Karthik |
SVP, Clinical Solutions |
|
2023-03-01 |
4 |
D |
$140.69 |
$9,145 |
D/D |
(65) |
9,839 |
|
- |
|
Rusckowski Stephen H |
Director |
|
2023-03-01 |
4 |
D |
$140.69 |
$491,852 |
D/D |
(3,496) |
345,570 |
|
- |
|
Davis J. E. |
CEO and President |
|
2023-03-01 |
4 |
D |
$140.69 |
$181,771 |
D/D |
(1,292) |
95,466 |
|
- |
|
Doherty Catherine T. |
SVP, Regional Businesses |
|
2023-03-01 |
4 |
D |
$140.69 |
$55,150 |
D/D |
(392) |
68,527 |
|
- |
|
Prevoznik Michael E |
SVP & General Counsel |
|
2023-03-01 |
4 |
D |
$140.69 |
$45,021 |
D/D |
(320) |
39,120 |
|
- |
|
Deppe Michael J |
SVP, Corp. Controller & CAO |
|
2023-03-01 |
4 |
D |
$140.69 |
$9,567 |
D/D |
(68) |
32,260 |
|
- |
|
Plewman Patrick |
SVP for Diagnostic Services |
|
2023-03-01 |
4 |
D |
$140.69 |
$12,662 |
D/D |
(90) |
10,566 |
|
- |
|
Doherty Catherine T. |
SVP, Regional Businesses |
|
2023-02-24 |
4 |
AS |
$141.42 |
$239,000 |
D/D |
(1,690) |
68,919 |
|
-0% |
|
Prevoznik Michael E |
SVP & General Counsel |
|
2023-02-24 |
4 |
AS |
$141.42 |
$200,109 |
D/D |
(1,415) |
39,440 |
|
-0% |
|
Delaney Mark E |
SVP & Chief Commercial Officer |
|
2023-02-23 |
4 |
A |
$0.00 |
$0 |
D/D |
1,919 |
3,650 |
|
- |
|
787 Records found
|
|
Page 4 of 32 |
|
|